Member Info for neilrich3

News about an acquisition could land any day, can't acquire another company and keep it a secret up until 29/06.

The appointment of David Franks was not to maintain the status quo, there's plenty going on behind the scenes, the daily drag upon the share price is just unfortunate.

https://twitter.com/NjbBari3/status/1401633663972831232

Anything is possible upon AIM......ASOS, JET2, NCYT.....the list goes on!

https://twitter.com/NovacytGroup/status/1400340252800208901

"Leading the Novacyt Group entry & scaling into the Americas markets" so what exactly has Guillermo Raimondo been doing since January, should this not have been his job? Nothing like a bit of competition within the company, wonder who can sell the most Guillermo or Kev.

Vice President? So who's the America's president? Guillermo Raimondo perhaps.

Domestic flights within the UK from Heathrow, for instance Heathrow to Glasgow, are carrying a mix of domestic passengers and passengers from both green and amber list countries, all mixing.

https://twitter.com/DrEricDing/status/1399695228853014538

Another massive jump in the wrong direction for people testing positive and for hospital admissions.

I'm connected to a regional airport, relatively small when compared to the likes of Manchester, Gatwick and Edinburgh. Have been reliably informed that the airport has sold 1.6 million COVID tests to date.

I don't know the precise breakdown, the above figure is the total for PCR and Antigen.

Assuming a 50/50 split that would be 800,000 PCR tests since October, the supplier is Primerdesign, therefore at £10 a test that would be £8 million revenue for Novacyt from just one UK airport.

Just consider the potential for larger airports, testing to continue for the foreseeable future.

Interesting, perhaps too close to the truth?

Sorry, not sure about the price for Today's Versalab portable.

Q16 approx £4500
Q32 approx £10k

I'm puzzled by the following sentence from Today's RNS: "The initial market response to the portfolio is encouraging and the Company looks to increase its promotion during the second half of 2021."

Wonder why we are waiting until H2 before increasing promotion of the Versalab portfolio? Surly you'd increase promotion immediately.

Any thoughts?

Unfortunately nothing more than speculation, one day they might be right.

Also, you conveniently ignore that PCR can be used in so many other fields from Cancer detection to antimicrobial resistance (the number one threat to health) and that Novacyt is a world leader in this field with already in excess of 500 tests.

So you're predicting that the market cap in two years shall be approximately £71 million, at which point NCYT shall have approximately £350 million cash in the bank. Although likely to have made a number of acquisitions by then.

You ignore the fact that at this time less than 10% of the global population has received the first dose vaccine.

You ignore the fact that we are not vaccinating children.

You are not allowing for variants and mutation and the continued need for surveillance. Should we stop testing, variants shall enter the UK unknown and the country will be back to March 2020.

Already plenty applicants after just 24 hours.

Not a bug, more a case of these new roles being advertised in hurry, these were listed Saturday night/Sunday morning upon an existing template, hence the details stating Southampton, however pretty confident that these are in India.

ROBERT OGILVY WATSON
Robert previously served as Secretary to the UK Panel on Takeovers and Mergers, working closely with the UK government, the European Parliament, and the European Commission on the adoption of the EU Takeover Directive. Robert maintains strong connections with the Panel and financial advisors specialising in public M&A.